<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03528213</url>
  </required_header>
  <id_info>
    <org_study_id>2015_56</org_study_id>
    <secondary_id>2017-002393-39</secondary_id>
    <nct_id>NCT03528213</nct_id>
  </id_info>
  <brief_title>Utility of Sodium Lactate Infusion During Septic Shock</brief_title>
  <acronym>ULIS1</acronym>
  <official_title>Utility of Sodium Lactate Infusion During Septic Shock: Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      ULIS-1 is an open-label pilot study concerning utility of molar sodium lactate in fluid
      balance in septic shock patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ULIS-1 consists in three arms of treatment during the first 24hrs of septic shock treatment.

        -  normal saline

        -  sodium lactate 2.5ml/kg in 60min then

        -  either 0.25 or 0.5ml/kg/h during 24hrs Main criteria is fluid balance at 48hrs
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2018</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>bolus then continuous infusion of molar sodium lactate (2 doses) or normal saline</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>fluid balance</measure>
    <time_frame>at 48 hours</time_frame>
    <description>fluid balance</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>fluid balance at day 7</measure>
    <time_frame>Day 7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA (Sequential Organ Failure Assessment)</measure>
    <time_frame>Day 1, Day 2, Day 3, Day 7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>death in Intensive Care Unit (ICU)</measure>
    <time_frame>Day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of patients dead</measure>
    <time_frame>Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>death in hospital</measure>
    <time_frame>Day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>catecholamines free days</measure>
    <time_frame>Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ventilator free days</measure>
    <time_frame>Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>renal replacement therapy free days</measure>
    <time_frame>Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>new kidney failure</measure>
    <time_frame>Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nosocomial infections</measure>
    <time_frame>day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hypernatremia</measure>
    <time_frame>Day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hypokaliemia</measure>
    <time_frame>Day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>metabolic alkalosis</measure>
    <time_frame>day 2</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>at physician discretion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sodium lactate light dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>bolus 2.5ml/kg lactate 60min then 0.25ml/kg/h during 24hrs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sodium lactate high dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>bolus 2.5ml/kg lactate 60min then 0.50ml/kg/h during 24hrs</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Lactate light dose</intervention_name>
    <description>bolus 2.5ml/kg then 0.25ml/kg/h</description>
    <arm_group_label>Sodium lactate light dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Lactate high dose</intervention_name>
    <description>bolus 2.5ml/kg then 0.5ml/kg/h</description>
    <arm_group_label>Sodium lactate high dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>normal saline at physician discretion</description>
    <arm_group_label>Normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  septic shock (sepsis 3 definition)

          -  need to fluid administration &lt;6hrs of norepinephrine introduction

          -  social insurance

        Exclusion Criteria:

          -  pregnancy

          -  cardiac arrest

          -  more than 50ml/kg of fluid loading

          -  chronic renal failure with chronic hemodialysis or the investigators estimate a need
             for renal replacement therapy in the following 24hrs

          -  child C or acute liver failure with PT&lt;40% (unless AVK)

          -  plasmatic sodium &lt;120 or &gt;145mmol/l

          -  metabolic alkalosis with pH&gt;7.45
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raphaël Favory, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raphaël Favory, MD,PhD</last_name>
    <phone>03 20 44 54 94</phone>
    <phone_ext>+33</phone_ext>
    <email>raphael.favory@chru-lille.fr</email>
  </overall_contact>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2018</study_first_submitted>
  <study_first_submitted_qc>May 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2018</study_first_posted>
  <last_update_submitted>May 16, 2018</last_update_submitted>
  <last_update_submitted_qc>May 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sepsis</keyword>
  <keyword>fluid balance</keyword>
  <keyword>metabolism</keyword>
  <keyword>ischemia-reperfusion</keyword>
  <keyword>treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

